|
|
Study on the mechanism of intervention of Shenyuan Granules in diabetic nephropathy based on IRE-1α/NF-κB pathway |
ZHOU Yikun WANG Xiaoqin |
Clinical School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430060, China
|
|
|
Abstract Objective To investigate the mechanism of intervention of Shenyuan Granules in diabetic nephropathy (DN) based on IRE-1α/NF-κB pathway. Methods Forty SPF grade 7-week-old db/db male mice with body weight of (40±2) g were selected and divided into model group and Shenyuan Granules low-dose, medium-dose, and high-dose groups with ten mice in each group according to random number table method. Ten 7-week-old wild-type WT male mice of the same strain with SPF grade and body weight of (20±2) g were selected as blank control group. After one week of adaptive feeding, fasting blood glucose was detected in model group and Shenyuan Granules low-dose, medium-dose, and high-dose groups, and DN was determined by fasting blood glucose ≥16.7 mmol/L for three consecutive times, urine volume >150% of blank control group, and continuous proteinuria. Subsequently, Shenyuan Granules low-dose, medium-dose, and high-dose groups were given 1.5, 3.0, and 6.0 g/(kg·d) Shenyuan Granules intragastrically, respectively, while model group and blank control group were given the same amount of double steam water intragastrically, all five groups were given continuous intragastrically for 12 weeks. After the experiment, five kidney tissues of groups were collected and stained with hematoxylin-eosin to observe the pathological changes of kidney. Real-time polymerase chain reaction was used to detect the mRNA expression of GRP78, XBP-1S, IRE-1α, and NF-κB in the five groups, and the protein expressions of GRP78 and XBP-1S, and the phosphorylation levels of IRE-1α and NF-κB in the five groups were detected by Western blot. Results No obvious lesions were observed in the blank control group, while the model group had abnormal renal tissue structure, glomerular atrophy, and partial renal tubule dilatation. Compared with the model group, Shenyuan Granules low-dose, medium-dose, and high-dose groups showed some improvements. The mRNA expression of GRP78, XBP-1S, IRE-1α, NF-κB, and the protein expression of GRP78, XBP-1S in model group were higher than those in blank control group, and the levels of p-IRE-1α /IRE-1α and p-NF-κB /NF-κB were higher than those in blank control group, the differences were highly statistically significant (P<0.01). The mRNA expression of GRP78, XBP-1S, IRE-1α, NF-κB, and the protein expression of GRP78, XBP-1S in Shenyuan Granules low-dose, medium-dose, and high-dose groups were lower than those in model group, and the levels of p-IRE-1α/IRE-1α and p-NF-κB/NF-κB were lower than those in model group, the differences were statistically significant (P<0.05 or P<0.01). The mRNA expression of GRP78, XBP-1S, IRE-1α, NF-κB, and the protein expression of XBP-1S in Shenyuan Granules high-dose group were lower than those in Shenyuan Granules medium-dose and low-dose groups, and the levels of p-IRE-1α/IRE-1α and p-NF-κB/NF-κB were lower than those in Shenyuan Granules medium-dose and low-dose groups, the protein expression of GRP78 in Shenyuan Granules high-dose group was lower than that in Shenyuan Granules low-dose group; the levels of IRE-1α mRNA, GRP78 protein, XBP-1S protein, and p-IRE-1α/IRE-1α in Shenyuan Granules medium-dose group were lower than those in Shenyuan Granules low-dose group, and the differences were statistically significant (P<0.05 or P<0.01). Conclusion Shenyuan Granules may inhibit excessive endoplasmic reticulum stress response through IRE-1α/NF-κB pathway to reduce renal inflammation, improve renal function, and inhibit the progression of DN.
|
|
|
|
|
[1] 冯文帅,冯志海,靳鸽,等.早期糖尿病肾病的防治进展[J].中国中医药现代远程教育,2023,21(2):185-188.
[2] 董昱辛,纳仁高娃,刘远帆,等.糖尿病肾病的研究进展[J].中国当代医药,2021,28(9):35-38.
[3] Ahmad AA,Draves SO,Rosca M. Mitochondria in Diabetic Kidney Disease [J]. Cells,2021,10(11):2945.
[4] 李君,李见,王世信.糖尿病肾病发展为终末期肾病潜在机制的生物信息学研究[J].中国医药科学,2021,11(17):61-64.
[5] 赵进喜,王世东,黄为钧.中医药防治糖尿病及其并发症研究述评[J].世界中医药,2017,12(1):10-15.
[6] 王琼,朱燕亭,闫晓辉,等.糖尿病肾病患者贫血与肾功能、微炎性状态的相关性分析[J].疑难病杂志,2022,21(6):609-612,618.
[7] Chen J,Hou XF,Wang G,et al. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses [J]. J Ethnopharmacol,2016,193:433-444.
[8] Lu M,Lawrence DA, Marsters S,et al. Opposing unfolded- protein-response signals converge on death receptor 5 to control apoptosis [J]. Science,2014,345(6192):98- 101.
[9] Ron D,Hubbard SR. How IRE1 reacts to ER stress [J]. Cell,2008,132:24-26.
[10] Aouichat S,Navarro-Alarcon M,Alarcón-Guijo P,et al. Mel- atonin Improves Endoplasmic Reticulum Stress-Mediated IRE1α Pathway in Zücker Diabetic Fatty Rat [J]. Pharmaceuticals(Basel),2021,14(3):232.
[11] Oakes SA. Endoplasmic Reticulum Stress Signaling in Cancer Cells [J] Am J Pathol,2020,190(5):934-946.
[12] Krishnan S,Manoharan J,Wang H,et al. CD248 induces a maladaptive unfolded protein response in diabetic kidney disease [J]. Kidney Int,2023,103(2):304-319.
[13] 邓丹芳,孙龙,林腊梅.肾元颗粒通过线粒体介导平滑肌细胞凋亡对糖尿病肾病模型小鼠血管钙化的改善作用[J].中国中医药杂志,2021,36(5):2641-2646.
[14] 陈立,王小琴.Klotho基因调控的FGF23/FGFR1信号通路对人肾小管上皮细胞羟化酶表影响及肾元颗粒的干预作用[J].中华中医药杂志,2019,34(10):4547-4552.
[15] 王岚,朱国双,王小琴.基于Klotho调控的TGF-β1/Egr1信号通路探讨肾元颗粒对db/db糖尿病肾病小鼠肾脏保护作用[J].中华中医药杂志,2021,36(8):5033- 5036.
[16] 宋纯东,张霞,宋丹丹.益气养阴活血方对糖尿病肾病大鼠肾组织WT1影响的实验研究[J].中国中医基础医学杂志,2016,22(5):626-627,629.
[17] 陈奇.中药药理学研究方法[M].北京:人民卫生出版社,2006.
[18] Hetz C,Glimcher LH. Fine-tuning of the unfolded protein response:Assembling the IRE1alpha interactome [J]. Mol Cell,2009,35(5):551-561.
[19] Demirtas L,Guclu A,Erdur FM,et al. Apoptosis,autophagy & endoplasmic reticulum stress in diabetes mellitus [J]. Indian J Med Res,2016,144(4):515-524.
[20] Cunard R. Endoplasmic Reticulum Stress in the Diabetic Kidney,the Good,the Bad and the Ugly [J]. J Clin Med,2015, 4(4):715-740.
[21] 唐咸玉,曾慧妍.从内质网应激探讨2型糖尿病合并肥胖的脾虚痰湿病机[J].广州中医药大学学报,2019,36(7):1102-1105.
[22] 吕林,王凤云,唐旭东,等.基于内质网功能探讨“脾主运化”“脾主统血”的科学内涵[J].中医杂志,2015,56(14):1174-1177.
[23] 石艳霞.戴恩来教授治疗糖尿病肾病临床经验[J].中医临床研究,2019,11(7):64-66.
[24] 刘禹辛,尚晓玲,何泽.何泽基于开阖枢理论谈早中期消渴肾病“毒损肾络”的机理与治疗[J].中医药导报,2022,28(6):141-144.
[25] 袁忠钊,郑淇丹,何立群,等.何立群教授糖尿病肾病临证组方分析[J].中国医药导报,2022,19(8):147-150.
[26] 贺璞玉,倪青.倪青治疗糖尿病肾病的思路与方法[J].中医药报,2022,28(2):184-187,192.
[27] 朱清,王学艺,韩佳瑞,等.中药干预糖尿病肾病肾小管损伤的研究进展[J].中国医药,2023,18(5):787-792.
[28] 孟思璇,姚兴梅,吴歆叶,等.黄芪有效成分治疗糖尿病肾病的机制研究进展[J].中国医药导报,2023,20(4):60- 63.
[29] 王岚,朱国双,孙龙,等.肾元颗粒对db/db糖尿病肾病小鼠血管钙化的改善作用及其机制[J].吉林大学学报(医学版),2020,46(3):431-438,669. |
|
|
|